ANNE PUGGINI: Open Payments
NPI 1548749690 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 34 payments from 8 companies in 2025. Trend: 2023 $2,473 · 2024 $1,306 · 2025 $1,084
Food & beverage: $985Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $289 |
| GENZYME CORPORATION | 7 | $223 |
| Madrigal Pharmaceuticals | 5 | $222 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $163 |
| ABBVIE INC. | 3 | $87 |
| PFIZER INC. | 2 | $56 |
| QOL Medical, LLC | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, DUPIXENT, RINVOQ, VELSIPITY, Sucraid, CREON.
Industry payments across AZ — which companies pay providers there.
